Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomized study
FI: 11,99
Type: Article
Collaboration
Year: 2019
Writers
Bonifazi, F; Solano, C; Wolschke, C; Sessa, M; Patriarch, F; Zallio, F; Nagler, A; Selleri, C; Risitano, AM; Messina, G; Bethge, W; Herrera, P; Sureda, A; Carella, AM; Cimminiello, M; Guidi, S; Finke, J; Sorasio, R; Ferra, C; Sierra, J; Russo, D; Benedetti, E; Milone, G; Benedetti, F; Heinzelmann, M; Pastore, D; Jurado, M; Terruzzi, E; Narni, F; Volp, A; Ayuk, F; Ruutu, T; Kroger, N
Magazine
Title: LANCET HAEMATOLOGY
Quartile
- D1